These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 3110733
21. Respiratory distress syndrome in the tiny baby. Fawcett WA, Gluck L. Clin Perinatol; 1977 Sep; 4(2):411-23. PubMed ID: 332436 [No Abstract] [Full Text] [Related]
24. [Current therapy of respiratory distress syndrome in the newborn infant]. Stannigel H. Gynakologe; 1992 Jun; 25(3):164-8. PubMed ID: 1505797 [No Abstract] [Full Text] [Related]
25. Surfactant replacement therapy in the neonate: beyond respiratory distress syndrome. Donn SM, Dalton J. Respir Care; 2009 Sep; 54(9):1203-8. PubMed ID: 19712497 [Abstract] [Full Text] [Related]
26. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Engle WA, American Academy of Pediatrics Committee on Fetus and Newborn. Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434 [Abstract] [Full Text] [Related]
27. Surfactant protein B deficiency: a rare but lethal condition in newborn. Acharyya S, Acharyya K. Indian Pediatr; 2001 Sep; 38(9):1039-41. PubMed ID: 11568382 [No Abstract] [Full Text] [Related]
32. Effect of exogenous surfactant on the development of bronchopulmonary dysplasia in a baboon hyaline membrane disease model. Maeta H, Raju TN, Vidyasagar D, Bhat R, Esterly J, Matsuda H, Shimada S, Krukenkamp IB, Shanklin DR. Crit Care Med; 1990 Apr 02; 18(4):403-9. PubMed ID: 2318051 [Abstract] [Full Text] [Related]
33. A morphometrical study of the aeration of the pulmonary parenchyma in neonatal hyaline membrane disease. Lauweryns J, Deleersnyder M, Boussauw L. Beitr Pathol; 1971 Apr 02; 144(4):344-59. PubMed ID: 5158463 [No Abstract] [Full Text] [Related]
34. Hyaline membrane disease and a related spectrum of neonatal pneumopathies. Rosan RC. Perspect Pediatr Pathol; 1975 Apr 02; 2():15-60. PubMed ID: 1129028 [No Abstract] [Full Text] [Related]
35. [State of the pulmonary surfactant in fetal asphyxia and neonatal pneumopathies]. Birkun AA, Nesterov EN, Kobozev GV, Oleĭnik AI, Zavarzina GA. Vopr Okhr Materin Det; 1979 Aug 02; 24(8):12-7. PubMed ID: 582640 [No Abstract] [Full Text] [Related]
36. Benefits of nasal intermittent mandatory ventilation for preterms. Meneses J. J Pediatr; 2007 Nov 02; 151(5):e19; author reply e19-20. PubMed ID: 17961677 [No Abstract] [Full Text] [Related]
37. Hyaline membrane disease. Effect of surfactant prophylaxis on lung morphology in premature primates. Cutz E, Enhörning G, Robertson B, Sherwood WG, Hill DE. Am J Pathol; 1978 Sep 02; 92(3):581-94. PubMed ID: 99046 [Abstract] [Full Text] [Related]
38. [Pulmonary surfactant]. Murakami K, Ono K, Fujiwara T, Sawada H, Mori I. Nihon Ishikai Zasshi; 1971 Jul 01; 66(1):100-16. PubMed ID: 4254974 [No Abstract] [Full Text] [Related]
40. Composition and function of pulmonary surfactant and its implication in respiratory distress syndrome of the neonate. Morris DC. Ohio Med; 1990 Jul 01; 86(7):547-50. PubMed ID: 2392271 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]